AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics
- Posted on June 19, 2026
- By Financial Times
- 1 Views
- 1 min read
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics
Buyout comes amid an uptick in biotech dealmaking as Big Pharma seeks to bolster its drug pipelines